Bispebjerg Hospital is one of the hospitals in the Capital Region of Denmark. Along with a number of other hospitals and the University of Copenhagen, Bispebjerg Hospital forms part of the Copenhagen University Hospital. The hospital is a teaching hospital for medical students from Copenhagen University.

During the past decade, Bispebjerg Hospital, University of Copenhagen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bispebjerg Hospital, University of Copenhagen" are "Psoriasis" (2 trials). Many other conditions were trialed in "Bispebjerg Hospital, University of Copenhagen" in a lesser frequency.

Most popular intervention types in "Bispebjerg Hospital, University of Copenhagen" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "CP-690,550" (1 trials), "Etanercept 50 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bispebjerg Hospital, University of Copenhagen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bispebjerg Hospital, University of Copenhagen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Bispebjerg Hospital, University of Copenhagen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bispebjerg Hospital, University of Copenhagen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".